InMed Pharmaceuticals (NASDAQ: INM) pairs innovative therapeutic development in Alzheimer’s, ophthalmology, and dermatology with recurring revenue from its BayMedica manufacturing division — giving investors rare small-cap biotech exposure to high-impact science with reduced financing risk. INM-901 takes a multi-pathway approach to Alzheimer’s, targeting several core drivers of the disease rather…
Mark Skousen of Forecasts & Strategies shares his outlook for gold, silver and the US economy. ‘We’ve entered an…
1911 Gold Corporation (‘1911 Gold’ or the ‘Company’) (TSXV: AUMB,OTC:AUMBF) (OTCBB: AUMBF) (FRA: 2KY) is pleased to announce new…
American Rare Earths Limited (ARR:AU) has announced Optimisation Update Download the PDF here. This post appeared first on investingnews.com
The following is a list of Upcoming Meeting Dates for Reporting Issuers in Canada. The data is supplied by…
Steve Penny, founder of SilverChartist.com, explains why he currently has a bullish outlook for gold, silver and platinum, as…
John Feneck, portfolio manager and consultant at Feneck Consulting, shares his outlook for gold and silver prices and stocks.…
1911 Gold Corporation (‘1911 Gold’ or the ‘Company’) (TSXV: AUMB) (OTCQB: AUMBF) (FRA: 2KY) is pleased to announce that the Manitoba…
Questcorp Mining Inc. (CSE: QQQ,OTC:QQCMF) (OTCQB: QQCMF) (FSE: D910) (the ‘Company’ or ‘Questcorp’) completed the first tranche of its…